HER2 intra-tumor genomic heterogeneity is the co-existence of multiple tumor cell populations with discernibly different levels of HER2 expression within the same tumor, which has been reported in up to half of breast cancers [32, 41–43]. Here, ERBB2 is linked to breast carcinoma.